Skip to content
Block & Leviton logo
Prefer to talk to a person?(888) 256-2510
Securities Class Action · CVRx, Inc. (CVRX)

Lost money in CVRx, Inc. stock? You may be able to recover your losses.

Oklahoma Police Pension and Retirement System v. CVRx, Inc. et al., No. 0:26-cv-04746 (D. Minn.)

A federal securities class action has been filed on behalf of CVRx, Inc. (CVRX) investors. Find out in about 30 seconds whether you may be eligible to participate, at no cost.

  • No cost to participate
  • No fee unless investors recover
  • Talk to a real person, not a call center
Lead plaintiff deadline
January 8, 2027
52 days remaining
Class period
Jul 25, 2023 – Aug 6, 2026
Eligible purchases fall between these dates

What happened to CVRX

CLASS PERIOD$2.39$15.97$29.55Jul 2023Jul 2024Aug 2025Aug 2026Aug 7, 2026CVRX closes down 59.8%Jul 25, 2023Class period beginsAug 6, 2026CVRx discloses DOJ civilinvestigative demand; cutsoutlook
Daily closing prices for CVRX, adjusted for splits. Annotations summarize allegations in the complaint; they are not findings of any court.

About this case

The lawsuit alleges that CVRx misled investors about how it grew sales of Barostim, its heart failure device, and whether its sales team had stabilized. According to the complaint, CVRx generated some revenue through improper marketing, kickbacks to healthcare providers, and false information provided to government health insurance programs. The complaint also alleges that sales staff turnover remained high and that new hires needed more training and time to become productive. On August 6, 2026, CVRx disclosed that it had received a civil investigative demand from the U.S. Department of Justice as part of a False Claims Act investigation. That same day, CVRx cut its revenue outlook, citing fewer sales territories and lower sales productivity. CVRx shares fell 60% the next trading day.

The allegations, in plain terms

  1. July 25, 2023
    The class period begins. The complaint alleges that from this point CVRx misled investors about how it was growing sales of Barostim, its heart failure device, and about whether its sales team had stabilized.
  2. During the class period
    Per the complaint, CVRx generated some of its revenue through improper marketing, kickbacks to healthcare providers, and false information given to government health insurance programs.
  3. During the class period
    The complaint also alleges that sales staff turnover stayed high and that new hires needed more training and more time before they became productive, contrary to the picture allegedly presented to investors.
  4. August 6, 2026
    The company disclosed that it had received a civil investigative demand from the U.S. Department of Justice as part of a False Claims Act investigation. The same day, CVRx cut its revenue outlook, citing fewer sales territories and lower sales productivity.
  5. August 7, 2026
    CVRx shares fell about 60% on the next trading day following the August 6 disclosures.

Summarizes allegations in the complaint — they are not findings of any court.

Selective

We screen hundreds of stock drops every year and file only a handful. If we're investigating this one, it's because we believe in it.

Senior

Block & Leviton is run by the partners whose names are on the door — and our clients deal with them directly, whatever the size of the loss. That's the point of staying small.

Staying power

A dismissed case turned into a $150 million record.* A recovery from a company that went bankrupt. We build cases to go the distance — not to settle cheap.

* Subject to court approval. Prior results do not guarantee a similar outcome.

Who we are — and why we're involved

Block & Leviton represents investors. We never represent the companies we investigate. When a company's own disclosures reveal that shareholders were misled, we investigate and bring claims to recover those losses.

Our clients are people like you: individual investors, retirees, and pension funds harmed when the truth comes out and a stock falls. There is no cost to you to participate, and attorneys' fees are paid only out of a recovery approved by the court.

Who you'll be dealing with

Jake Walker

Jake Walker

Partner, Block & Leviton LLP

Represents investors in securities class actions nationwide.

Your first call will usually be with David White, our investor liaison — and our partners are directly involved in every case.

A record courts have trusted

Record result

NextEra Energy — $150 million

The district court dismissed the case. We appealed — and won a unanimous reversal in the Eleventh Circuit Court of Appeals. The result: a $150 million settlement — the largest securities class action settlement in the Southern District of Florida in more than 30 years.*

Biogen — $18.9 million*

Dismissed — then revived when we persuaded the court to reconsider its own judgment. Settled in 2026.

Tricida — $14.25 million

Recovered for investors even after Tricida itself went bankrupt.

Federal courts have appointed Block & Leviton lead counsel in securities class actions on behalf of investors nationwide. Our attorneys have recovered billions of dollars for investors, retirees, and pension funds.

* Subject to court approval. Prior results do not guarantee a similar outcome. Attorney advertising.

Common questions

Will this cost me anything?

No. There is no cost to submit your information, no cost to participate, and no out-of-pocket cost ever. If there's a recovery, attorneys' fees are paid from it and must be approved by the court.

I'm already part of the class automatically — so why submit my information?

It's true: if you bought CVRX during the class period, you're a class member whether or not you contact anyone. Submitting your information lets us evaluate your specific losses, keep you informed as the case develops, and tell you whether you may benefit from a larger role in the case.

What is a lead plaintiff?

The lead plaintiff is an investor the court appoints to represent the class, typically someone with a significant loss. Lead plaintiffs oversee the litigation on behalf of everyone and are entitled to seek reimbursement for their time. The deadline to seek appointment in this case is January 8, 2027.

I sold my shares after the drop — am I still eligible?

Possibly, yes. What generally matters is that you purchased shares during the class period and were harmed by the decline. Whether you still hold shares today doesn't necessarily disqualify you — submit your details and we'll evaluate your situation.

Does submitting this form make you my lawyers?

No — and that's a protection for you. Submitting the form only lets us evaluate your potential claim, at no cost. If we determine we can help and you decide to move forward, we'll send you a written retainer agreement that spells out the relationship, the contingency fee, and your rights. You're never committed to anything until you've read and signed it.

What happens after I submit the form?

Our team reviews your submission — usually within one business day. David, our investor liaison, will reach out by phone or email, and our partners are directly involved in every case. You're never obligated to do anything.

Attorney advertising. Prior results do not guarantee a similar outcome. Block & Leviton LLP is responsible for the content of this page. Submitting information through this page does not create an attorney-client relationship.

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.

Get in Touch